Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Liabilities and Shareholders Equity (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Liabilities and Shareholders Equity for 9 consecutive years, with $37.3 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 23.98% to $37.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $136.8 million through Dec 2025, up 42.1% year-over-year, with the annual reading at $37.3 million for FY2025, 23.98% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $37.3 million at SANUWAVE Health, up from $35.6 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $37.3 million in Q4 2025, with the low at $17.5 million in Q1 2023.
  • Average Liabilities and Shareholders Equity over 3 years is $26.0 million, with a median of $22.9 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity increased 7.38% in 2024, then surged 62.97% in 2025.
  • Over 3 years, Liabilities and Shareholders Equity stood at $22.4 million in 2023, then surged by 34.36% to $30.1 million in 2024, then grew by 23.98% to $37.3 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $37.3 million, $35.6 million, and $33.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.